Vir Biotechnology Commercial Paper Liability (Annual Per Share) Analysis

Vir Biotechnology, Inc. (VIR)

9.00 -0.10 (-1.10%) USD | NASDAQ | Mar 06, 12:38

View Commercial Paper Liability (Annual Per Share) for VIR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Annual Per Share) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Annual Per Share) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Annual Per Share) Benchmarks

Start Trial

Hims & Hers Health, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Xeris Biopharma Holdings, Inc.	--
Gossamer Bio, Inc.	--
Sensei Biotherapeutics, Inc.	--